Company profile
OmniSeq company profile
OmniSeq offers physicians and their patients of the most actionable tumor-profiling information possible. OmniSeq, an innovation of Roswell Park Cancer Institute, is a molecular diagnostic laboratory. It endeavors to find the right drug or the right trial for every patient. It also offers NY State CLEP approved assays, including OmniSeq Comprehensive, a 144 gene NGS assay that covers almost all known genetic alterations associated with an FDA-approved targeted therapy or genotype directed clinical trial. OmniSeq is also making significant investments to create better diagnostics for immuno-oncology therapy selection. The company was founded in 2015 and is based in Buffalo, New York.
Business identity
- Website
- https://www.omniseq.com/
- Contact email
- [email protected]
- Phone number
- 1(800)781-1259
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $0-$1M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Spicer, Minnesota, United States
- Postal code
- 14203
- Country code
- US
- Continent
- North America